Compile Data Set for Download or QSAR
maximum 50k data
Found 28
TargetAdenosine receptor A2(Bos taurus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50438367(CHEMBL2413102)
Affinity DataKi:  11nMAssay Description:Displacement of [3H]CGS21680 from adenosine A2A receptor in bovine striatal membranes after 90 mins by liquid scintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99205(US8501708, 29)
Affinity DataKi:  422nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99192(US8501708, 12)
Affinity DataKi:  476nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Homo sapiens (Human))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM108256(CHEMBL2205239 | US8609833, 87)
Affinity DataKi:  951nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99210(US8501708, 34)
Affinity DataKi:  2.27E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99193(US8501708, 13)
Affinity DataKi:  2.53E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99206(US8501708, 30)
Affinity DataKi:  2.55E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  2.77E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99202(US8501708, 22)
Affinity DataKi:  2.98E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99204(US8501708, 28)
Affinity DataKi:  3.37E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 14 | US8501708, 15)
Affinity DataKi:  3.74E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  3.78E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Homo sapiens (Human))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM97465(US8470800, B | US8609833, 85)
Affinity DataKi:  4.19E+3nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Homo sapiens (Human))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM97464(US8470800, A | US8609833, 17)
Affinity DataKi:  4.69E+3nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99197(US8501708, 17)
Affinity DataKi:  5.32E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99199(US8501708, 19)
Affinity DataKi:  5.54E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99201(US8501708, 21)
Affinity DataKi:  6.83E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99198(US8501708, 18)
Affinity DataKi:  7.33E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Bos taurus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50487424(CHEMBL2261733)
Affinity DataKi:  7.90E+3nMAssay Description:Displacement of [3H]CGS21680 from adenosine A2A receptor in Bos taurus (bovine) cortical membraneMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
TargetAdenosine receptor A2(Homo sapiens (Human))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM108258(US8609833, 91)
Affinity DataKi:  9.11E+3nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99203(US8501708, 23)
Affinity DataKi:  9.37E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Homo sapiens (Human))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM108257(US8609833, 88)
Affinity DataKi:  1.00E+4nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99200(US8501708, 20)
Affinity DataKi:  1.14E+4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Bos taurus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50487423(CHEMBL2261736)
Affinity DataKi:  1.50E+4nMAssay Description:Displacement of [3H]CGS21680 from adenosine A2A receptor in Bos taurus (bovine) cortical membraneMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99208(US8501708, 32)
Affinity DataKi:  1.56E+4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 14 | US8501708, 15)
Affinity DataKi:  2.54E+4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99196(US8501708, 16)
Affinity DataKi: >1.00E+5nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Homo sapiens (Human))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM97467(US8470800, D | US8609833, 93)
Affinity DataKi: >1.00E+5nMAssay Description:The affinities of selected Purine Derivatives for the adenosine A1 receptor were determined by measuring the displacement of specific [3H] 2-chloro-N...More data for this Ligand-Target Pair
In DepthDetails US Patent